HOME - Clinical cases - Implantology
 
 
20 November 2019

Osteointegration of titanium implant in patients treated with antiangiogenic targeted chemotherapy

Lara Figini


Recent advances in dental implants have led to an increase in the number of patients treated, with survival rates of more than 95% in a healthy population. More and more frequently dental implant are performed in elderly subjects or in people who have undergone chemotherapy treatments for cancer. Traditional chemotherapy is characterized by a lack of selectivity for tumor cells, that can may lead to drug resistance or result in systemic toxicity. Recently, better targeted treatments, which depend on monoclonal antibodies (mAb) that bind to specific targets on the surface of tumour cells, have been introduced. These differ from traditional treatments as they target cancer cell apoptosis by blocking oncogenic pathways and restricting angiogenesis.
These new chemotherapy drugs, thanks to their selectivity, guarantee fewer side effects, however, require longer treatment times than the traditional ones. But the antiangiogenic targeted chemotherapy can affect the osseointegration of dental implant?

Materials and Methods
In an in vitro animal study, published on British Journal of Oral and Maxillofacial Surgery  February 2019, the authors examined the effect of targeted anti-angiogenetic chemotherapy on the osseointegration of titanium implants. Fourteen white rabbits were allocated randomly into two groups of seven: the placebo control group and the Avastin® group. Animals in the Avastin® group had five doses of bevacizumab intraperitoneally (3 mg/kg/week). The first was given two days before the implant was inserted and the remaining four were given weekly for four weeks. One titanium implant was inserted in the right distal femoral condyle of each rabbit. Osseointegration of the implants was measured using microcomputed tomography (CT) and histomorphometric evaluation.

Results
Both microcomputed tomography and histomorphometric evaluation showed less osseointegration in the Avastin® group than in the controls.

Conclusions
From the data of this study, which must be confirmed with other similar studies and in clinical trials in humans, it can be concluded that the pharmacological inhibition of angiogenesis by bevacizumab can negatively influence the osseointegration of titanium implants on animals.

Clinical implications
The dentist have to  take into consideration that in cases of implantology in patients in therapy or recent undergoned  with chemotherapy-targeted antiangiogenic drugs, the osseointegration can be negatively affected by the intake of bevacizumab specifically.

For additional informations:  Effect of antiangiogenic targeted chemotherapy on the osseointegration of titanium implants in rabbits.

Italian version: http://www.odontoiatria33.it/implantologia/17721/osteointegrazione-di-impianti-dentali-in-pazienti-in-cura-con-i-recenti-chemioterapici.html

Related articles

There is still no accordance on the antibiotic prophylaxis regimen to prevent failures or postoperative infections in healthy patients undergoing standard implant surgery.Some authors proposed...


Dental implantology is currently a routine therapy performed on young patients but also on older patients, with or without systemic diseases. Despite the fact that dental implant therapy has been...


Treatments using dental implants to replace missing teeth are effective and predictable. However, with the ever-growing popularity of implant treatments and...


It is estimated that 1 in 2 women and 1 in 5 men over the age of 50 may develop a fracture due to osteoporosis. Osteoporosis is defined as a skeletal disease...


Nowadays patients with fully edentulous maxilla may benefit from different prosthetic rehabilitations. One of them  is the implant-supported overdenture...


Read more

In the last decade, the development of new technologies has moved in parallel with a rapid evolution of restorative materials on the rails of Digital...


In the latest issue of European Journal of Orthodontics (April 2020) a clinical practice guideline on orthodontically induced external apical root resorption ...


Title: Luting strategies for adhesive dentistryAuthor: Prof. Lorenzo BreschiWhen: September 17 th, 2020Time: 11am west coast - 2pm east coast - 8pm GTM+2 Price: $ 49.99...


Author: Luigi Campopiano

1. In the light of the fact that the 9 trillion euro of Italian savings are more than 90 % invested in Italy in euros, it is a good idea to expand the scope of investments to other markets that...


This state-of-the-art review presents the latest evidence and the current status of autogenous soft tissue grafting for soft tissue augmentation and recession...


 
 
 
 

Newsletter

 
 
 
 

Most popular

 
 

Events